ENTITLED An Act to classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Be it enacted by the Legislature of the State of South Dakota:

Section 1. That a NEW SECTION be added to chapter 34-20B:

Any material, compound, mixture, or preparation that contains medetomidine is a Schedule III controlled drug or substance, except in the following cases:

(1) Dispensing, prescribing, or administering, to an animal, a drug that contains medetomidine and has been approved by the United States secretary of health and human services under 21 U.S.C. § 360b (January 1, 2026);

(2) Dispensing, prescribing, or administering medetomidine to an animal, as permissible under 21 U.S.C. § 360b(a)(4) (January 1, 2026);

(3) Manufacturing, distributing, or using medetomidine as an active pharmaceutical ingredient for manufacturing an animal drug:

(a) Approved under 21 U.S.C. § 360b (January 1, 2026); or

(b) Issued an investigational use exemption under 21 U.S.C. § 360b(j) (January 1, 2026);

(4) Manufacturing, distributing, or using a medetomidine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian; or

(5) Any other use approved or permissible under 21 U.S.C. §§ 301 to 399i, inclusive (January 1, 2026).

An Act to classify medetomidine as a Schedule III controlled substance and establish permissible uses.